Alós Juan-Ignacio
Servicio de Microbiología, Hospital Universitario de Getafe, Getafe, Madrid, España; Facultad de Ciencias Biomédicas, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, España.
Enferm Infecc Microbiol Clin. 2015 Dec;33(10):692-9. doi: 10.1016/j.eimc.2014.10.004. Epub 2014 Dec 1.
The introduction of antibiotics into clinical practice represented one of the most important interventions for the control of infectious diseases. Antibiotics have saved millions of lives and have also brought a revolution in medicine. However, an increasing threat has deteriorated the effectiveness of these drugs, that of bacterial resistance to antibiotics, which is defined here as the ability of bacteria to survive in antibiotic concentrations that inhibit/kill others of the same species. In this review some recent and important examples of resistance in pathogens of concern for mankind are mentioned. It is explained, according to present knowledge, the process that led to the current situation in a short time, evolutionarily speaking. It begins with the resistance genes, continues with clones and genetic elements involved in the maintenance and dissemination, and ends with other factors that contribute to its spread. Possible responses to the problem are also reviewed, with special reference to the development of new antibiotics.
抗生素引入临床实践是控制传染病最重要的干预措施之一。抗生素挽救了数百万人的生命,也给医学带来了一场革命。然而,一个日益严重的威胁削弱了这些药物的有效性,即细菌对抗生素的耐药性,这里将其定义为细菌在抑制/杀死同种其他细菌的抗生素浓度下存活的能力。在这篇综述中,提到了一些近期人类关注的病原体耐药性的重要例子。根据目前的知识,从进化的角度解释了在短时间内导致当前状况的过程。它从耐药基因开始,接着是与维持和传播有关的克隆和遗传元件,最后是促成其传播的其他因素。还综述了针对该问题可能的应对措施,特别提及了新型抗生素的研发。